USFDA & EU Essentials of Drug Safety and Pharmacovigilance 2012
March 5 - 7, 2012(Ended)
Mumbai, India
USFDA & EU Essentials of Drug Safety and Pharmacovigilance is a seminar that covers topics such as:
- Assessing Adverse Event Cases
- Overview of Pharmacovigilance
- Global Regulatory Requirements
- Reporting Adverse Events
- Pharmacovigilance Best Practices
- Inspections and Audits
- Case Studies with Real-Life Inspection Findings
- Preparing for an Inspection
- Pharmacovigilance and Risk Management Process
- Background to Signal Detection
- Signalling and Data Mining Exercises
USFDA & EU Essentials of Drug Safety and Pharmacovigilance brings together Regulatory Affairs, Pharmacoepidemiology , Pharmacovigilance Specialists, Clinical Safety Staff, Quality Management Specialists, Regulatory Affairs Professionals, Regulatory Affairs, Drug Safety and Pharmacovigilance, Executives with any Legal Responsibility for Drug Safety and Clinical Development.
Venue
Not final
Address
Mumbai,
India
India
Prices *
18000-20000 Indian Rupee (Early registration date: February 18, 2012)
Organization
Categories
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Medical Seminars for All in the Field
- Infection Control
- Determine the prevalence of hypermetropia among young male and female
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Absract : Percutaneous Nephrolithotomy(PCNL): 10 years Experience with 7200 cases, Report of Results and Complications in Southern Iran
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters
